(FY)Jun 30, 2024 | (FY)Jun 30, 2023 | |
---|---|---|
Operating Cash Flow (Indirect Method) | ||
Cash flow from continuing operating activities | ||
Cash from discontinued investing activities | ||
Investing cash flow | ||
Cash flow from continuing investing activities | 89.32%-102.07K | -955.93K |
Net PPE purchase and sale | 77.94%-254.73K | ---1.15M |
Cash from discontinued investing activities | ||
Investing cash flow | 89.32%-102.07K | ---955.93K |
Financing cash flow | ||
Cash flow from continuing financing activities | -94.93%572.52K | 11.29M |
Net common stock issuance | -93.42%748.75K | --11.38M |
Net other financing activities | -107.78%-166.93K | ---80.34K |
Cash from discontinued financing activities | ||
Financing cash flow | -94.93%572.52K | --11.29M |
Net cash flow | ||
Beginning cash position | -27.94%11.84M | --16.44M |
Current changes in cash | -121.06%-10.15M | ---4.59M |
End cash Position | -85.72%1.69M | --11.84M |
Free cash flow | 31.60%-11M | ---16.08M |
Currency Unit | AUD | AUD |
Accounting Standards | US-GAAP | US-GAAP |
No Data